Debjit Chattopadhyay

Biotechnology Equity Research

Established firm's foot print in biotechnology equity research which resulted in primary revenue increasing by 10%. Performed due diligence and developed detailed financial models, sales forecasts and identified acquisition candidates which grossed clients over 55%. Evaluated public and private companies and assisted investment bankers with go / no-go decisions resulting in direct investments in excess of $80 M.

Stream lined resource allocation, increased efficiency and improved project margins by 12%. Provided leadership and oversight to the medical business unit and supervised the creation of promotional content for Novartis transplant franchise and Baxter Biotherapeutics. Contributed to 5% increase in myfortic sales by identifying key messaging gaps through primary market research with transplant surgeons as the primary audience. Drove new business initiatives and increased sales by 15% by coordinating efforts between multiple internal stake holders. Collaborated with Novartis brand, regulatory and medical affairs teams leading to the development of branded and non-branded initiatives to engage key opinion leaders and promote product differentiation.

• Stream lined resource allocation, increased efficiency and improved project margins by 12%. Provided leadership and oversight to the medical business unit and supervised the creation of promotional content for Novartis transplant franchise and Baxter Biotherapeutics. • Contributed to 5% increase in myfortic sales by identifying key messaging gaps through primary market research with transplant surgeons as the primary audience. • Drove new business initiatives and increased sales by 10% by coordinating efforts between multiple internal stake holders. • Collaborated with Novartis brand, regulatory and medical affairs teams leading to the development of branded and non-branded initiatives to engage key opinion leaders and promote product differentiation.